Abstract: A filter having a pass band includes a series circuit in which a series arm resonator and a first inductor are connected in series with each other and which forms at least part of a signal path R connecting a first input/output terminal and a second input/output terminal and a parallel arm resonator connected between one end of the series circuit and a ground. The series circuit becomes inductive in the pass band. An anti-resonant frequency of the series arm resonator is higher than a frequency at a higher-frequency end of the pass band. A resonant frequency of the parallel arm resonator is higher than the anti-resonant frequency of the series arm resonator.

Abstract: A filter includes a first input/output electrode and the second input/output electrode, and is arranged on a first main surface of a mounting substrate. The mounting substrate includes a first land electrode, a second land electrode, a ground terminal, and a plurality of via conductors. The first land electrode is connected to the first input/output electrode. The second land electrode is connected to the second input/output electrode. The ground terminal is located closer to a second main surface side than the first main surface in a thickness direction of the mounting substrate. The plurality of via conductors is arranged between the first main surface and the second main surface, and is connected to the ground terminal. The plurality of via conductors is located between the first land electrode and the second land electrode in a plan view from the thickness direction of the mounting substrate.

Abstract: A high-frequency module includes a mounting substrate, a filter, and a common inductor. The mounting substrate includes a first main surface and a second main surface facing each other. The filter includes series arm resonators and parallel arm resonators, and is disposed on the first main surface. The mounting substrate includes a ground terminal on the second main surface. A first end of the common inductor is connected to all of the parallel arm resonators. A second end of the common inductor is connected to the ground terminal.

Abstract: A wing flapping apparatus including a frame body, a motive power source and a power transmission mechanism that transmits motive power generated in the motive power source to drive a wing unit. Moreover, the power transmission mechanism includes a slider that linearly reciprocates in an X-axis direction upon reception of the motive power transmitted from the motive power source, and a rotating body that reciprocates in a rotation direction upon reception of the motive power transmitted from the slider. Furthermore, the wing unit swings such that its distal end moves approximately in the X-axis direction as the rotating body reciprocates in the rotation direction. In this aspect, linear reciprocation of the slider and swinging of the wing unit in the X-axis direction are opposite in direction to each other.

Abstract: A wing flapping apparatus includes a motive power source; a power transmission mechanism; and a wing unit driven by the power transmission mechanism. The power transmission mechanism includes a rotation transmission member configured to rotate upon reception of motive power transmitted from the motive power source; a slider configured to linearly reciprocate in an X-axis direction upon reception of the motive power transmitted from the rotation transmission member and a rotating body configured to reciprocate in a rotation direction upon reception of the motive power transmitted from the slider. The wing unit is configured to swing such that its distal end moves approximately in the X-axis direction as the rotating body reciprocates in the rotation direction. The power transmission mechanism further includes a pair of crank arms each configured to connect the rotation transmission member and the slider.

Abstract: The problem to be solved by the present invention is to provide a novel compound having RET inhibitory activity. The present invention also provides a pharmaceutical preparation that is useful for the prevention and/or treatment of RET-related diseases, particularly cancer, based on RET inhibitory activity. The present invention provides a compound represented by Formula (I): wherein A, R2, and X are as defined in the specification; or a salt thereof.

Abstract: The present invention provides a novel RET inhibitor comprising, as an active ingredient, a compound or a salt thereof that have not been known for their RET inhibitory activity, and also provides an agent for preventing or treating diseases (e.g., malignant tumors) that can be prevented or treated by RET inhibitory activity. The RET inhibitor comprises, as an active ingredient, a compound represented by Formula (I) below or a salts thereof: wherein A, R1 to R3, X, and n are as defined in the specification.

Abstract: The problem to be solved by the present invention is to provide a novel compound having RET inhibitory activity. The present invention also provides a pharmaceutical preparation that is useful for the prevention and/or treatment of RET-related diseases, particularly cancer, based on RET inhibitory activity. The present invention provides a compound represented by Formula (I): wherein A, R2, and X are as defined in the specification; or a salt thereof.

Abstract: A powder transport apparatus includes a first transport path disposed in the first transport path, a second transport path connected to the first transport path through a first connection port and a junction port, a third transport path connected to the second transport path through a second connection port, a second transport member that is disposed in the second transport path and includes a first shaft provided with a first spiral blade that transports powder toward the first connection port, a second spiral blade that is provided in a portion of the first shaft between the first connection port and the junction port and that has a transport force smaller than a transport force of the first spiral blade in the one direction, and a third transport member disposed in the third transport path. The third transport member transports the powder toward the second connection port.

Abstract: The present invention provides a novel RET inhibitor comprising, as an active ingredient, a compound or a salt thereof that have not been known for their RET inhibitory activity, and also provides an agent for preventing or treating diseases (e.g., malignant tumors) that can be prevented or treated by RET inhibitory activity. The RET inhibitor comprises, as an active ingredient, a compound represented by Formula (I) below or a salts thereof: wherein A, R1 to R3, X, and n are as defined in the specification.

Abstract: A filter includes a resonant circuit defining at least a portion of a signal path connected between a first terminal and a second terminal, an elastic wave resonator including one end that is grounded, a first inductor including one end connected to one end of the resonant circuit and another end connected to another end of the elastic wave resonator, and a second inductor including one end connected to another end of the resonant circuit and another end connected to the other end of the elastic wave resonator. The resonant circuit is an LC series resonant circuit in which a third inductor and first and second capacitors are connected in series with each other.

Abstract: A developing device includes a developer carrier on which an attraction region is set, the attraction region being a region that attracts developer including toner and a carrier, and that carries, in the attraction region, the developer that is to be supplied to an image carrier on which an electrostatic latent image is formed; a regulation member that regulates the developer so that a predetermined amount of the developer is carried by the developer carrier; and a forming unit that is located upstream of the regulation member and that forms, in the attraction region, a first region that restricts a flow of developer supplied to the developer carrier and a second region that is located between the first region and the regulation member and that does not restrict a flow of the developer compared with the first region.

Abstract: The problem to be solved by the present invention is to provide a novel compound having RET inhibitory activity. The present invention also provides a pharmaceutical preparation that is useful for the prevention and/or treatment of RET-related diseases, particularly cancer, based on RET inhibitory activity. The present invention provides a compound represented by Formula (I): wherein A, R2, and X are as defined in the specification; or a salt thereof.

Abstract: A hybrid multiplexer includes a filter configured to allow a high-frequency signal of an HB to pass therethrough, and a filter configured to allow a high-frequency signal of an MB to pass therethrough, in which the filter includes a matching circuit, a first resonance circuit defined by one of an LPF and an HPF, and a second resonance circuit defined by the other of the LPF and the HPF, the LPF includes an inductor and a parallel arm resonator, the HPF includes a serial arm resonator and an inductor, and a resonant frequency of the parallel arm resonator and an anti-resonant frequency of the serial arm resonator are both located between a frequency at a low-band end of the HB and a frequency at a high-band end of the HB.

Abstract: An image forming apparatus includes: an image carrier in which a latent image is formed; a developing device that transfers toner to the latent image from a developing member opposed to the image carrier, and develops the latent image; a development power supply that applies a development voltage across the image carrier and the developing member; a period detector that detects periodic information on the developing member and the image carrier in a circumferential direction; and a corrector that corrects the development voltage or an exposure amount of the latent image based on the periodic information detected by the period detector. At least one of the developing device and the development power supply is set so that a supply rate of charge of the toner to the latent image in a solid area of an image reaches 80% or higher.

Abstract: A developing device includes a developer carrier on which an attraction region is set, the attraction region being a region that attracts developer including toner and a carrier, and that carries, in the attraction region, the developer that is to be supplied to an image carrier on which an electrostatic latent image is formed; a regulation member that regulates the developer so that a predetermined amount of the developer is carried by the developer carrier; and a forming unit that is located upstream of the regulation member and that forms, in the attraction region, a first region that restricts a flow of developer supplied to the developer carrier and a second region that is located between the first region and the regulation member and that does not restrict a flow of the developer compared with the first region.

Abstract: The present invention provides a novel RET inhibitor comprising, as an active ingredient, a compound or a salt thereof that have not been known for their RET inhibitory activity, and also provides an agent for preventing or treating diseases (e.g., malignant tumors) that can be prevented or treated by RET inhibitory activity. The RET inhibitor comprises, as an active ingredient, a compound represented by Formula (I) below or a salts thereof: wherein A, R1 to R3, X, and n are as defined in the specification.

Abstract: A developing device includes: a housing unit that has an opening and houses a developer; a conveying member that is installed within the housing unit and conveys the developer; a first rotating member that has an outer peripheral surface to which the developer conveyed by the conveying member adheres; a regulating unit that protrudes above a movement path of the developer that adheres to the outer peripheral surface and moves due to rotation of the first rotating member, and regulates movement of some of the developer on the outer peripheral surface; and a second rotating member that is installed in the opening and has supplied thereto the developer that has moved through a gap between the first rotating member and the regulating unit.

Abstract: The present invention provides a novel RET inhibitor comprising, as an active ingredient, a compound or a salt thereof that have not been known for their RET inhibitory activity, and also provides an agent for preventing or treating diseases (e.g., malignant tumors) that can be prevented or treated by RET inhibitory activity. The RET inhibitor comprises, as an active ingredient, a compound represented by Formula (I) below or a salts thereof: wherein A, R1 to R3, X, and n are as defined in the specification.

Abstract: The present invention provides a novel RET inhibitor comprising, as an active ingredient, a compound or a salt thereof that have not been known for their RET inhibitory activity, and also provides an agent for preventing or treating diseases (e.g., malignant tumors) that can be prevented or treated by RET inhibitory activity. The RET inhibitor comprises, as an active ingredient, a compound represented by Formula (I) below or a salts thereof: wherein A, R1 to R3, X, and n are as defined in the specification.